Upgrade to SI Premium - Free Trial

AstraZeneca (AZN) Receives Positive EMA CHMP Opinion on Zavicefta as cIAI, cUTI, and HAP Treatment

April 29, 2016 7:53 AM
On 28 April 2016 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles